Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Other Accumulated Expenses (2021 - 2026)

Cingulate's (CINGW) quarterly Other Accumulated Expenses came in at $27275.0 in Q2 2026, down 23.35% on a YoY basis from $35586.0 in Q2 2025, and down 68.91% quarter-over-quarter from $87742.0 in Q4 2025.

Analysis

Cingulate (CINGW) Other Accumulated Expenses (2021 - 2026) Analysis & Trends

Cingulate (CINGW) has reported Other Accumulated Expenses for 6 consecutive years, with $27275.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Accumulated Expenses fell 23.35% year-over-year to $27275.0; the trailing twelve-month figure through Jun 2026 stood at $27275.0 (down 23.35% YoY), and the FY2025 full-year result was $87742.0, up 55.36% from the prior year.
  • Other Accumulated Expenses eased to $27275.0 in Q2 2026 per CINGW's latest filing, from $87742.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $326742.0 in Q3 2022 and bottomed at $16107.0 in Q2 2023.
  • Historically, Other Accumulated Expenses has averaged $91560.4 across 5 years, with a median of $55363.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses slumped 94.87% in 2023, then jumped 159.66% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $55363.0 in 2022, then rose by 20.83% to $66897.0 in 2023, then retreated by 15.58% to $56476.0 in 2024, then jumped by 55.36% to $87742.0 in 2025, then slumped by 68.91% to $27275.0 in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $27275.0, $87742.0, and $59455.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.10 Bn 625.34 Bn 17.26 Bn
2 AbbVie 441.68 Bn 435.11 Bn 12.70 Bn
3 Merck 366.62 Bn 359.48 Bn 12.21 Bn
4 Novartis Ag 266.55 Bn 258.86 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn
7 Revolution Medicines 44.07 Bn 44.07 Bn -
8 Incyte 25.59 Bn 21.05 Bn 1.57 Bn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn
10 Cingulate 100,214.03 100,214.03 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27,275.00
Dec 31, 2025 87,742.00
Sep 30, 2025 59,455.00
Jun 30, 2025 35,586.00
Mar 31, 2025 22,809.00
Dec 31, 2024 56,476.00
Sep 30, 2024 27,450.00
Jun 30, 2024 25,850.00
Mar 31, 2024 74,569.00
Dec 31, 2023 66,897.00
Sep 30, 2023 28,127.00
Jun 30, 2023 16,107.00
Mar 31, 2023 28,718.00
Dec 31, 2022 55,363.00
Sep 30, 2022 326,742.00
Jun 30, 2022 314,097.00
Mar 31, 2022 303,263.00
Dec 31, 2021 295,595.00